 Matthew Galbraith
Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclin-Dependent Kinase 8 | 7 | 2021 | 38 | 1.770 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 110 | 1.420 |
Why?
| | Tumor Suppressor Protein p53 | 9 | 2023 | 449 | 1.320 |
Why?
| | Interferons | 5 | 2023 | 152 | 1.310 |
Why?
| | Transcriptome | 4 | 2022 | 736 | 1.290 |
Why?
| | Down Syndrome | 6 | 2023 | 336 | 1.280 |
Why?
| | Transcription, Genetic | 9 | 2021 | 1310 | 1.260 |
Why?
| | Transcriptional Activation | 9 | 2023 | 340 | 1.090 |
Why?
| | Mediator Complex | 3 | 2013 | 52 | 0.920 |
Why?
| | Neoplasms | 8 | 2023 | 2118 | 0.820 |
Why?
| | Blood | 1 | 2022 | 97 | 0.780 |
Why?
| | Proteome | 2 | 2022 | 345 | 0.770 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.740 |
Why?
| | Genomics | 2 | 2021 | 646 | 0.660 |
Why?
| | RNA Polymerase II | 7 | 2019 | 283 | 0.610 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 1893 | 0.590 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2021 | 249 | 0.550 |
Why?
| | Cell Hypoxia | 2 | 2017 | 220 | 0.550 |
Why?
| | ets-Domain Protein Elk-1 | 2 | 2013 | 13 | 0.530 |
Why?
| | Protein Kinase Inhibitors | 2 | 2018 | 790 | 0.530 |
Why?
| | Mitogens | 2 | 2013 | 58 | 0.520 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 157 | 0.500 |
Why?
| | Serum Response Element | 2 | 2011 | 5 | 0.460 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 20 | 0.440 |
Why?
| | Signal Transduction | 7 | 2023 | 4541 | 0.390 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1122 | 0.370 |
Why?
| | Anemia, Sickle Cell | 2 | 2023 | 217 | 0.350 |
Why?
| | Humans | 40 | 2023 | 115589 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2021 | 1147 | 0.310 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 2751 | 0.300 |
Why?
| | Nuclear Proteins | 4 | 2023 | 594 | 0.290 |
Why?
| | Cell Proliferation | 6 | 2023 | 2194 | 0.280 |
Why?
| | Glutamine | 2 | 2023 | 91 | 0.280 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 286 | 0.260 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 465 | 0.260 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1316 | 0.250 |
Why?
| | Pantoea | 1 | 2004 | 2 | 0.250 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2004 | 5 | 0.250 |
Why?
| | Phenazines | 1 | 2004 | 9 | 0.240 |
Why?
| | Datasets as Topic | 2 | 2022 | 99 | 0.240 |
Why?
| | Apoptosis | 6 | 2023 | 2377 | 0.240 |
Why?
| | Animals | 15 | 2023 | 32102 | 0.240 |
Why?
| | Hypoxia | 3 | 2023 | 937 | 0.230 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 15 | 0.230 |
Why?
| | HCT116 Cells | 3 | 2019 | 69 | 0.230 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.220 |
Why?
| | Fibroblasts | 2 | 2019 | 839 | 0.220 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 14 | 0.220 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2023 | 147 | 0.220 |
Why?
| | Hematopoiesis | 2 | 2021 | 173 | 0.220 |
Why?
| | HeLa Cells | 3 | 2013 | 567 | 0.210 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 131 | 0.200 |
Why?
| | Transcription Factors | 3 | 2023 | 1528 | 0.200 |
Why?
| | Medulloblastoma | 1 | 2023 | 172 | 0.200 |
Why?
| | Enteritis | 1 | 2022 | 82 | 0.200 |
Why?
| | Imidazoles | 2 | 2020 | 217 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 388 | 0.190 |
Why?
| | Erythrocytes | 2 | 2023 | 589 | 0.190 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 187 | 0.190 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 26 | 0.190 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 78 | 0.180 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 140 | 0.180 |
Why?
| | Oncogenes | 1 | 2021 | 104 | 0.180 |
Why?
| | Piperazines | 2 | 2020 | 314 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 208 | 0.180 |
Why?
| | Proteomics | 2 | 2023 | 859 | 0.180 |
Why?
| | RNA Helicases | 1 | 2020 | 20 | 0.180 |
Why?
| | Cell Line | 3 | 2021 | 2651 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 57 | 0.170 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 231 | 0.170 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 60 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2022 | 295 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 186 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.160 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.160 |
Why?
| | Complement Activation | 1 | 2021 | 343 | 0.150 |
Why?
| | Complement System Proteins | 1 | 2021 | 288 | 0.150 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 390 | 0.150 |
Why?
| | Hexokinase | 1 | 2017 | 10 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2022 | 3022 | 0.150 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 11 | 0.150 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 30 | 0.150 |
Why?
| | Deoxyglucose | 1 | 2017 | 43 | 0.150 |
Why?
| | Mice | 9 | 2023 | 15052 | 0.150 |
Why?
| | Autoimmunity | 1 | 2023 | 822 | 0.150 |
Why?
| | Homeostasis | 1 | 2021 | 577 | 0.150 |
Why?
| | Gene Editing | 1 | 2017 | 59 | 0.140 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 362 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 659 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 346 | 0.140 |
Why?
| | Lysine Acetyltransferase 5 | 1 | 2016 | 2 | 0.140 |
Why?
| | Purines | 1 | 2017 | 159 | 0.140 |
Why?
| | Osteosarcoma | 1 | 2017 | 66 | 0.140 |
Why?
| | Acetylation | 2 | 2016 | 212 | 0.140 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 157 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 150 | 0.140 |
Why?
| | Glycolysis | 1 | 2017 | 224 | 0.140 |
Why?
| | Comorbidity | 1 | 2021 | 1473 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 726 | 0.130 |
Why?
| | Histone Acetyltransferases | 1 | 2016 | 50 | 0.130 |
Why?
| | Conserved Sequence | 1 | 2016 | 219 | 0.130 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 137 | 0.130 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1483 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 331 | 0.130 |
Why?
| | Tretinoin | 1 | 2016 | 124 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 601 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 194 | 0.120 |
Why?
| | HEK293 Cells | 2 | 2016 | 602 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 535 | 0.120 |
Why?
| | DNA Helicases | 1 | 2016 | 133 | 0.120 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1048 | 0.120 |
Why?
| | Drosophila Proteins | 1 | 2016 | 159 | 0.120 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 190 | 0.120 |
Why?
| | Biomarkers | 2 | 2022 | 3467 | 0.120 |
Why?
| | Protein Binding | 4 | 2021 | 1917 | 0.110 |
Why?
| | Phosphorylation | 2 | 2019 | 1571 | 0.110 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 18 | 0.110 |
Why?
| | Models, Biological | 1 | 2021 | 1646 | 0.110 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 14 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 863 | 0.110 |
Why?
| | Genes, ras | 1 | 2013 | 91 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 577 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2013 | 68 | 0.110 |
Why?
| | Histones | 2 | 2016 | 540 | 0.100 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2012 | 10 | 0.100 |
Why?
| | Hospitalization | 1 | 2021 | 1765 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 46 | 0.100 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 26 | 0.100 |
Why?
| | Gene Silencing | 2 | 2023 | 175 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 731 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 3 | 2023 | 609 | 0.090 |
Why?
| | Yeasts | 1 | 2010 | 51 | 0.090 |
Why?
| | Phenotype | 3 | 2023 | 2829 | 0.090 |
Why?
| | MCF-7 Cells | 2 | 2020 | 105 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2020 | 1872 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 13 | 0.080 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 526 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 704 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2353 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2023 | 553 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2019 | 850 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2207 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2023 | 2604 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 61 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 60 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 2004 | 156 | 0.060 |
Why?
| | Hydroxyurea | 1 | 2023 | 30 | 0.060 |
Why?
| | Glutamates | 1 | 2023 | 59 | 0.060 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 18 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 40 | 0.060 |
Why?
| | Proline | 1 | 2023 | 72 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| | Kynurenine | 1 | 2023 | 80 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2004 | 309 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 47 | 0.050 |
Why?
| | Sphingosine | 1 | 2023 | 32 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2021 | 2574 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 3364 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 219 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 136 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 146 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2023 | 1700 | 0.050 |
Why?
| | Lysophospholipids | 1 | 2023 | 65 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 172 | 0.050 |
Why?
| | Cyclins | 1 | 2022 | 79 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1536 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 78 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 732 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 50 | 0.050 |
Why?
| | Clonal Evolution | 1 | 2021 | 27 | 0.050 |
Why?
| | Escherichia coli | 1 | 2004 | 730 | 0.050 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 281 | 0.050 |
Why?
| | Data Mining | 1 | 2021 | 100 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 23 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 30 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2020 | 57 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 9 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 84 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2790 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 136 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 64 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 352 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 167 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 75 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 31 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 362 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 321 | 0.040 |
Why?
| | Up-Regulation | 1 | 2021 | 820 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 815 | 0.040 |
Why?
| | Cell Survival | 1 | 2021 | 1024 | 0.040 |
Why?
| | Female | 5 | 2023 | 59913 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 560 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 385 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 296 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 538 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 209 | 0.030 |
Why?
| | Promyelocytic Leukemia Protein | 1 | 2016 | 4 | 0.030 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 2016 | 12 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 2016 | 11 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 164 | 0.030 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 31 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2114 | 0.030 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2016 | 45 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1168 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2016 | 32 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1083 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 129 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 369 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 204 | 0.030 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2016 | 91 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 317 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1650 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 369 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 438 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2418 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 544 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 3580 | 0.030 |
Why?
| | Monocytes | 1 | 2016 | 507 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 429 | 0.030 |
Why?
| | Caspase 8 | 1 | 2012 | 43 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 638 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 401 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 174 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3339 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1177 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 26998 | 0.020 |
Why?
| | Protein Transport | 1 | 2012 | 400 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4440 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 4773 | 0.020 |
Why?
| | Adult | 2 | 2021 | 30719 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 3914 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1756 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2008 | 28 | 0.020 |
Why?
| | RNA | 1 | 2014 | 819 | 0.020 |
Why?
| | Genes, fos | 1 | 2008 | 36 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 198 | 0.020 |
Why?
| | Mitochondria | 1 | 2012 | 750 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10470 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2008 | 553 | 0.020 |
Why?
| | Male | 2 | 2021 | 55949 | 0.020 |
Why?
| | Child | 1 | 2023 | 18489 | 0.020 |
Why?
|
|
Galbraith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|